Condition: Type 2 Diabetes (T2DM) · Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
This trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes
This description comes directly from the study's public registry record.
Tahapary · +62 821 1447 2567 · dicky.tahapary@ui.ac.id
Always discuss trial participation with your own doctor first.
| RS Universitas Indonesia | Depok, West Java, Indonesia | Recruiting |
| RSUP Fatmawati | Jakarta, Indonesia | Recruiting |
| RSUP Persahabatan | Jakarta, Indonesia | Recruiting |
| RSUPN Dr. Cipto Mangunkusumo | Jakarta, Indonesia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07064486